ADIPOQ and myeloid sarcoma: Our results were consistent with those of Wu et al., showing that adiponectin is a biomarker for evaluating T2DM and MS in men, whereas the G/A ratio benefited both men and women, suggesting that the combination of these two adipokines may have an “enhancing effect”.